Source:http://linkedlifedata.com/resource/pubmed/id/18511632
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-5-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1468-3296
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
479-80
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18511632-Acute Kidney Injury,
pubmed-meshheading:18511632-Anti-Bacterial Agents,
pubmed-meshheading:18511632-Case-Control Studies,
pubmed-meshheading:18511632-Cystic Fibrosis,
pubmed-meshheading:18511632-Gentamicins,
pubmed-meshheading:18511632-Humans,
pubmed-meshheading:18511632-Infusions, Intravenous
|
pubmed:year |
2008
|
pubmed:articleTitle |
Should we stop using intravenous gentamicin in patients with cystic fibrosis?
|
pubmed:publicationType |
Editorial,
Comment
|